Rhesus haemolytic disease of the newborn
Neonatal · Paediatric
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Alloimmune haemolysis from maternal anti-D (or other) antibodies crossing the placenta, causing neonatal anaemia, hyperbilirubinaemia and hydrops.
Red flags
- Hydrops fetalis
- Rapidly rising bilirubin
- Signs of kernicterus (lethargy, abnormal tone)
- Severe anaemia
Assessment
Differential diagnosis
- ABO haemolytic disease
- G6PD deficiency
- Hereditary spherocytosis
- Sepsis
- Other alloimmune anaemia
Investigations
- Neonatal FBC, reticulocytes, blood film
- Bilirubin (serial) and blood group / direct antiglobulin test
- Maternal antibody status
- LDH and haptoglobin
- Assess for hydrops
Management
- Assess for anaemia, jaundice and hydrops at birth
- Start intensive phototherapy for hyperbilirubinaemia
- Monitor bilirubin against exchange thresholds
- Transfuse for severe anaemia
- Exchange transfusion for very high or rising bilirubin
- Neonatal / haematology involvement
Drugs & doses
Intensive phototherapy
IVIG (specialist, to reduce haemolysis)
Packed red cells / exchange transfusion
Disposition
Neonatal unit; haematology input.
Complications & pitfalls
- Kernicterus
- Severe anaemia / heart failure
- Late anaemia of infancy
Exam pearls
- Antenatal anti-D prophylaxis has made severe disease uncommon.
- Follow national bilirubin threshold charts for phototherapy and exchange.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.